This podcast episode features an international panel discussion on the nuts and bolts of switching patients to long-acting injectable cabotegravir plus rilpivirine for HIV treatment.
This podcast episode features an international panel discussion on clinic-level considerations for incorporating long-acting ART into the HIV treatment paradigm.
This podcast episode features an international expert panel discussion on key considerations for using long-acting cabotegravir as HIV PrEP.
This podcast episode features an international expert panel discussion on what will be needed in future long-acting HIV treatment and prevention strategies to address populations who are not eligible for currently available long-acting options.
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.